Financial News
All News about Olema Pharmaceuticals Inc
![](https://cdn.benzinga.com/files/images/story/2023/09/05/image36.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where Olema Pharmaceuticals Stands With Analysts
September 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/05/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Olema Pharmaceuticals
August 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Olema Pharmaceuticals Q1 Earnings
May 09, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
Olema Oncology Announces Combined Financing for Up to $180 Million
September 05, 2023
From Olema Oncology
Via GlobeNewswire
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
From Olema Oncology
Via GlobeNewswire
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
From Olema Oncology
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/06/29/bioxcel_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/20/dice_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/20/surgalign_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/16/coherus_biosciences_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/16/squarespace_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/12/asset_entities_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
From Olema Oncology
Via GlobeNewswire
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
From Olema Oncology
Via GlobeNewswire
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
From Olema Oncology
Via GlobeNewswire
![](https://ml.globenewswire.com/media/aba52262-f4b6-4253-9fac-9e7a125c04b7/small/olema-oncology-high-res-logo-png.png)
From Olema Oncology
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.